SINO-AGRI LEADING BIOSCIENCES CO.,LTD Financials Sino-Agri Leading Biosciences Co.,Ltd
Equities
603970
CNE100002TN4
Agricultural Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.12 CNY | -1.95% |
|
-0.52% | +24.48% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,475 | 4,051 | 5,002 | 5,626 | 4,129 | 5,139 | - |
| Enterprise Value (EV) 1 | 2,475 | 4,051 | 5,002 | 5,626 | 4,129 | 5,139 | 5,139 |
| P/E ratio | 20.8 x | 30.6 x | 29.4 x | 26.7 x | 18.4 x | 17.4 x | 14.4 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 0.57 x | 0.61 x | - | 0.48 x | 0.39 x | 0.34 x | 0.29 x |
| EV / Revenue | 0.57 x | 0.61 x | - | 0.48 x | 0.39 x | 0.34 x | 0.29 x |
| EV / EBITDA | - | 18.3 x | - | 16.6 x | 12.6 x | 11.2 x | 9.34 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | 3.95 x | - | 4.27 x | 2.87 x | 2.66 x | 2.24 x |
| Nbr of stocks (in thousands) | 268,800 | 268,800 | 268,800 | 268,800 | 268,800 | 268,800 | - |
| Reference price 2 | 9.207 | 15.07 | 18.61 | 20.93 | 15.36 | 19.12 | 19.12 |
| Announcement Date | 4/21/20 | 4/19/21 | 4/18/22 | 4/18/23 | 4/18/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 4,342 | 6,641 | - | 11,699 | 10,460 | 15,028 | 17,730 |
| EBITDA 1 | - | 221.8 | - | 338.3 | 326.9 | 460 | 550 |
| EBIT 1 | - | 211.4 | - | 324.9 | 315.4 | 468 | 570 |
| Operating Margin | - | 3.18% | - | 2.78% | 3.02% | 3.11% | 3.21% |
| Earnings before Tax (EBT) 1 | - | 207.5 | - | 325.7 | 315.1 | 468 | 570 |
| Net income 1 | - | 132.4 | 170.3 | 210.3 | 224.8 | 295 | 359 |
| Net margin | - | 1.99% | - | 1.8% | 2.15% | 1.96% | 2.02% |
| EPS 2 | 0.4422 | 0.4927 | 0.6336 | 0.7825 | 0.8365 | 1.100 | 1.330 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 4/21/20 | 4/19/21 | 4/18/22 | 4/18/23 | 4/18/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 13.3% | - | 16.9% | 16.2% | 15.3% | 15.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | 3.7% | 3.9% |
| Assets 1 | - | - | - | - | - | 7,973 | 9,205 |
| Book Value Per Share 2 | - | 3.810 | - | 4.900 | 5.360 | 7.180 | 8.520 |
| Cash Flow per Share 2 | - | 1.310 | - | 5.710 | -3.510 | 2.240 | 2.670 |
| Capex 1 | - | - | - | - | - | 8 | 8 |
| Capex / Sales | - | - | - | - | - | 0.05% | 0.05% |
| Announcement Date | 4/21/20 | 4/19/21 | 4/18/22 | 4/18/23 | 4/18/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
19.12
CNY
Average target price
22.5
CNY
Spread / Average Target
+17.68%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +24.48% | 710M | |
| -2.20% | 800M | |
| -30.39% | 682M | |
| -12.00% | 317M | |
| -7.69% | 209M | |
| -.--% | 101M | |
| +24.69% | 83.72M |
- Stock Market
- Equities
- 603970 Stock
- Financials Sino-Agri Leading Biosciences Co.,Ltd
